MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
It will take 2-3 business days to deliver the report upon receipt the order if any customization is not there.
MRD Testing Trends and Forecast
The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $4.4 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
MRD Testing by Segment
The study includes a forecast for the global MRD testing by technology, application, end use industry, and region.
MRD Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies MRD testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the MRD testing companies profiled in this report include-
Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.
Within this market, hospitals and specialty clinics will remain the largest segment.
APAC is expected to witness highest growth over the forecast period.
Features of the Global MRD Testing Market
Market Size Estimates: MRD testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: MRD testing market size by various segments, such as by application, end use industry, and region in terms of value ($B).
Regional Analysis: MRD testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end use industries, and regions for the MRD testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the MRD testing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the MRD testing market size?
Answer: The global MRD testing market is expected to reach an estimated $4.4 billion by 2030.
Q.2 What is the growth forecast for MRD testing market?
Answer: The global MRD testing market is expected to grow with a CAGR of 12.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the MRD testing market?
Answer: The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
Q4. What are the major segments for MRD testing market?
Answer: The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets.
Q5. Who are the key MRD testing market companies?
Answer: Some of the key MRD testing companies are as follows:
Answer: Lucintel forecasts that next-generation sequencing (NGS) is expected to witness highest growth over the forecast period.
Q7. In MRD testing market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the MRD testing market by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Mrd Testing Market, Mrd Testing Market Size, Mrd Testing Market Growth, Mrd Testing Market Analysis, Mrd Testing Market Report, Mrd Testing Market Share, Mrd Testing Market Trends, Mrd Testing Market Forecast, Mrd Testing Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
MRD Testing Trends and Forecast
The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $4.4 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
MRD Testing by Segment
The study includes a forecast for the global MRD testing by technology, application, end use industry, and region.
MRD Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Flow Cytometry
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Others
- Hematological Malignancies
- Leukemia
- Lymphoma
- Solid Tumors
- Others
- Hospitals and Specialty Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies MRD testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the MRD testing companies profiled in this report include-
- Labcorp
- F. Hoffmann-La Roche
- Guardant Health
- Sysmex Corporation
- Neogenomics Laboratories
- Adaptive Biotechnologies Corporation
- Archerdx
- Asuragen
- Arup Laboratories
Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.
Within this market, hospitals and specialty clinics will remain the largest segment.
APAC is expected to witness highest growth over the forecast period.
Features of the Global MRD Testing Market
Market Size Estimates: MRD testing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: MRD testing market size by various segments, such as by application, end use industry, and region in terms of value ($B).
Regional Analysis: MRD testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end use industries, and regions for the MRD testing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the MRD testing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the MRD testing market size?
Answer: The global MRD testing market is expected to reach an estimated $4.4 billion by 2030.
Q.2 What is the growth forecast for MRD testing market?
Answer: The global MRD testing market is expected to grow with a CAGR of 12.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the MRD testing market?
Answer: The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
Q4. What are the major segments for MRD testing market?
Answer: The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets.
Q5. Who are the key MRD testing market companies?
Answer: Some of the key MRD testing companies are as follows:
- Labcorp
- F. Hoffmann-La Roche
- Guardant Health
- Sysmex Corporation
- NeoGenomics Laboratories
- Adaptive Biotechnologies Corporation
- ArcherDX
- Asuragen
- Arup Laboratories
Answer: Lucintel forecasts that next-generation sequencing (NGS) is expected to witness highest growth over the forecast period.
Q7. In MRD testing market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the MRD testing market by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Mrd Testing Market, Mrd Testing Market Size, Mrd Testing Market Growth, Mrd Testing Market Analysis, Mrd Testing Market Report, Mrd Testing Market Share, Mrd Testing Market Trends, Mrd Testing Market Forecast, Mrd Testing Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL MRD TESTING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global MRD Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global MRD Testing Market by Technology
3.3.1: Flow Cytometry
3.3.2: Polymerase Chain Reaction (PCR)
3.3.3: Next-Generation Sequencing (NGS)
3.3.4: Others
3.4: Global MRD Testing Market by Application
3.4.1: Hematological Malignancies
3.4.2: Leukemia
3.4.3: Lymphoma
3.4.4: Solid Tumors
3.4.5: Others
3.5: Global MRD Testing Market by End Use Industry
3.5.1: Hospitals and Specialty Clinics
3.5.2: Diagnostic Laboratories
3.5.3: Academic & Research Institutes
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global MRD Testing Market by Region
4.2: North American MRD Testing Market
4.2.2: North American MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
4.3: European MRD Testing Market
4.3.1: European MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
4.3.2: European MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
4.4: APAC MRD Testing Market
4.4.1: APAC MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
4.4.2: APAC MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
4.5: ROW MRD Testing Market
4.5.1: ROW MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
4.5.2: ROW MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global MRD Testing Market by Technology
6.1.2: Growth Opportunities for the Global MRD Testing Market by Application
6.1.3: Growth Opportunities for the Global MRD Testing Market by End Use Industry
6.1.4: Growth Opportunities for the Global MRD Testing Market by Region
6.2: Emerging Trends in the Global MRD Testing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global MRD Testing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MRD Testing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Labcorp
7.2: F. Hoffmann-La Roche
7.3: Guardant Health
7.4: Sysmex Corporation
7.5: NeoGenomics Laboratories
7.6: Adaptive Biotechnologies Corporation
7.7: ArcherDX
7.8: Asuragen
7.9: Arup Laboratories
2. GLOBAL MRD TESTING MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global MRD Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global MRD Testing Market by Technology
3.3.1: Flow Cytometry
3.3.2: Polymerase Chain Reaction (PCR)
3.3.3: Next-Generation Sequencing (NGS)
3.3.4: Others
3.4: Global MRD Testing Market by Application
3.4.1: Hematological Malignancies
3.4.2: Leukemia
3.4.3: Lymphoma
3.4.4: Solid Tumors
3.4.5: Others
3.5: Global MRD Testing Market by End Use Industry
3.5.1: Hospitals and Specialty Clinics
3.5.2: Diagnostic Laboratories
3.5.3: Academic & Research Institutes
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global MRD Testing Market by Region
4.2: North American MRD Testing Market
4.2.2: North American MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
4.3: European MRD Testing Market
4.3.1: European MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
4.3.2: European MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
4.4: APAC MRD Testing Market
4.4.1: APAC MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
4.4.2: APAC MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
4.5: ROW MRD Testing Market
4.5.1: ROW MRD Testing Market by Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Others
4.5.2: ROW MRD Testing Market by End Use Industry: Hospitals and Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global MRD Testing Market by Technology
6.1.2: Growth Opportunities for the Global MRD Testing Market by Application
6.1.3: Growth Opportunities for the Global MRD Testing Market by End Use Industry
6.1.4: Growth Opportunities for the Global MRD Testing Market by Region
6.2: Emerging Trends in the Global MRD Testing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global MRD Testing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MRD Testing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Labcorp
7.2: F. Hoffmann-La Roche
7.3: Guardant Health
7.4: Sysmex Corporation
7.5: NeoGenomics Laboratories
7.6: Adaptive Biotechnologies Corporation
7.7: ArcherDX
7.8: Asuragen
7.9: Arup Laboratories
